Explore evidence

41 %41% of clinicians knew saliva could be used in diagnosing HIV.

NigeriaVIH/sidapublished 2019The Pan African medical journalPubMeddocument of 17 observations

84 %Of 425 patients that were traced, 355 (84%) were alive and 70 (16%) were dead.

NigeriaVIH/sidapublished 2019PloS onePubMeddocument of 8 observations

8 yearsThe median time to first birth after HIV diagnosis was 8 years.

NigeriaVIH/sidaobserved 2015published 2020PloS onePubMeddocument of 4 observations

90 %Mother-to-child transmission accounts for 90% of all new paediatric HIV infections in Nigeria.

NigeriaVIH/sidapublished 2024BMC pregnancy and childbirthPubMeddocument of 8 observations

0.86 %Early infant diagnosis was positive for HIV among 13 infants (0.86%) of the 1,514 infants studied in Kano, northwest Nigeria.

NigeriaVIH/sidaobserved 2010 to 2016published 2021Current HIV researchPubMeddocument of 6 observations

210,000 casesIn 2023, over 210,000 new HIV acquisitions occurred in Kenya, Mozambique, Nigeria, Uganda and Zambia.

Kenya · Mozambique · Nigeria · Ouganda · ZambieVIH/sidaobserved 2023published 2025Journal of the International AIDS SocietyPubMeddocument of 2 observations

29 %Menstrual irregularities were found to be prevalent among Nigerian women living with HIV, varying from 29% to 76% across different regions.

NigeriaVIH/sidapublished 2024Reproductive healthPubMed

29 %Of the 483 patients with tuberculosis treated at the health facility between 2018 and 2022, 29.0% had TB/HIV coinfection.

Nigeriatuberculose · VIH/sidaobserved 2018-2022published 2024BMJ openPubMeddocument of 6 observations

0.01 aORClients on six-month multi-month dispensing had an adjusted odds ratio of 0.01 for interruption of antiretroviral therapy.

NigeriaVIH/sidapublished 2021BMC public healthPubMeddocument of 12 observations

16.3 %The prevalence of Herpes Simplex Virus Type-2 was 16.3% among HIV seronegative women.

NigeriaHerpes Simplex Virus Type-2 · VIH/sidapublished 2022Current HIV researchPubMeddocument of 4 observations

47.7 %47.7% of the study participants were HIV positive.

NigeriaVIH/sidaobserved 2020–2022published 2023BMC cancerPubMeddocument of 14 observations

32.7 %Mortality among HIV/AIDS admissions was 32.7%.

NigeriaVIH/sidapublished 2023West African journal of medicinePubMeddocument of 11 observations

10 patientsTen patients had resistance to their first-line drug(s).

NigeriaVIH/sidapublished 2020BMC microbiologyPubMeddocument of 7 observations

51.5 %HIV prevalence among transgender women (TGW) in Abuja and Lagos, Nigeria was 51.5%.

NigeriaVIH/sidaobserved 2013 to 2020published 2022Journal of the International AIDS SocietyPubMeddocument of 20 observations

56 %Of 6108 registered patients, 3397 (56%) were lost to follow-up from the Lagos University Teaching Hospital antiretroviral program.

NigeriaVIH/sidapublished 2019PloS onePubMeddocument of 8 observations

1.4 odds_ratioForced sexual initiation was significantly associated with infrequent condom use (OR = 1.4, 95% CI = 1.1–2.1) among youth in Nigeria, Uganda, and Zambia.

Nigeria · Ouganda · ZambieVIH/sidaobserved 2014 and 2015published 2019Child abuse & neglectPubMeddocument of 8 observations

79.3 %Among men living with HIV in Kano, Nigeria, 79.3% desired more children, compared to 91.1% of HIV-negative/untested controls.

NigeriaVIH/sidapublished 2020International journal of behavioral medicinePubMeddocument of 6 observations

10.1 %The overall HIV prevalence among 3229 study participants was 10.1%.

NigeriaVIH/sidaobserved 2009-12published 2016PloS onePubMeddocument of 14 observations

249 individualsAmong HIV-positive patients in Ilorin, Nigeria, 249 (64.8%) used active coping as a coping strategy.

NigeriaVIH/sidapublished 2021Nigerian journal of clinical practicePubMeddocument of 7 observations

9.4 %Comprehensive HIV knowledge was low among young adolescents in Akwa Ibom State, Nigeria, at 9.4%.

NigeriaVIH/sidaobserved 2017published 2020BMC public healthPubMeddocument of 5 observations

7.11 AORParticipants with pulmonary TB had a higher likelihood of favorable TB treatment outcome compared to those with extrapulmonary TB (adjusted odds ratio = 7.110, 95% confidence interval = 1.506–33.565).

Nigeriatuberculose · VIH/sidapublished 2024The Pan African medical journalPubMeddocument of 5 observations

4.7 %Among HIV-infected women attending a tertiary health facility in Kano, Nigeria, 4.7% ever used intrauterine insemination as a safer conception method.

NigeriaVIH/sidapublished 2019International journal of health policy and managementPubMeddocument of 10 observations

35.4 %Among individuals initiated on antiretroviral therapy more than 14 days after HIV diagnosis, 35.4% were lost to follow-up by 12 months in Nigeria.

NigeriaVIH/sidapublished 2023PloS onePubMeddocument of 3 observations

13.4 yearsAmong HIV-positive women, PhenoAge acceleration (PhenoAA) was on average 13.4 years higher in women with invasive cervical cancer compared to cancer-free women.

Nigeriacancer du col de l'utérus · VIH/sidapublished 2022Frontiers in public healthPubMeddocument of 4 observations

481 casesAmong 16,727 female sex workers on antiretroviral therapy in Nigeria between 1 January 2016 and 31 August 2022, 481 (3%) had transferred to other clinics for ART by 31 August 2022.

NigeriaVIH/sidaobserved 2016-01-01 to 2022-08-31published 2026BMC women's healthPubMeddocument of 11 observations